The heritability of failed smoking cessation and nicotine withdrawal in twins who smoked and attempted to quit.
paper
Cited
Public
Unavailable
- Authors
- Xian, Hong; Scherrer, Jeffrey F; Madden, Pamela A F; Lyons, Michael J; Tsuang, Ming; True, William R; Eisen, Seth A
- Year
- 2003
- Journal
- Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco
- PMID
- 12745498
The magnitude of the association between nicotine withdrawal and failed smoking cessation remains uncertain, and the potential genetic contribution to that relationship is unknown. We used a twin design study to test if genetic and environmental risk factors contribute to nicotine withdrawal and failed cessation. We then estimated the magnitude of genetic and environmental risk factors and the associated correlations. Cigarette consumption data were obtained in 1992 from 4,112 (1,806 pairs, 496 singletons) male twin pairs from the Vietnam Era Twin Registry. Participants responded to a telephone administration of the Diagnostic Interview Schedule. Odds ratios were computed for failed smoking cessation as a function of 12 individual nicotine withdrawal symptoms. Genetic model fitting was performed on a sample of 1818 twin pairs, all of whom were lifetime smokers; both twins of the pairs had made at least one quit attempt. After adjustment for cigarette consumption, odds of failed smoking cessation ranged from.87 (95% CI.76-.99) for "increased appetite/weight gain" to 1.85 (95% CI 1.55-2.22) for "depressed." Genetic influences accounted for 54% and 29.7% of the variance in risk for failed smoking cessation and nicotine withdrawal, respectively. The correlation between genetic influences was significant (r=.31, 95% CI.17-.45). The magnitude of the association between failed cessation and nicotine withdrawal varied by symptom. The risk of experiencing nicotine withdrawal after a quit attempt was related partly to genetic vulnerability; lifetime risk for both failed cessation and nicotine withdrawal was related partly to genetic factors that were correlated.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Comorbidity and Familial Aggregation of Mood Disorders and Cigarette Smoking in a Controlled Family Study. | Conway KP et al. | — | 2026 | → |
| Nicotine reward in the conditioned place preference test across a panel of male inbred mice and F1 crosses: genetic influence and correlation with variation in nicotine antinociception. | Buzzi B et al. | — | 2025 | → |
| Deep sequencing of candidate genes identified 14 variants associated with smoking abstinence in an ethnically diverse sample. | Cinciripini PM et al. | — | 2024 | → |
| Exercise and Smoking Cessation. | Garey L et al. | — | 2024 | → |
| Investigating the Relationship Between Smoking Behavior and Global Brain Volume. | Chang Y et al. | — | 2024 | → |
| Striatal Cholinergic Interneurons Control Physical Nicotine Withdrawal via Muscarinic Receptor Signaling. | Kim B et al. | — | 2024 | → |
| Adverse physiological effects of smoking cessation on the gastrointestinal tract: A review. | Mahyoub MA et al. | — | 2023 | → |
| A scoping review of smoking cessation pharmacogenetic studies to advance future research across racial, ethnic, and ancestral populations. | Prom-Wormley EC et al. | — | 2023 | → |
| The shared genetic architecture of smoking behaviours and psychiatric disorders: evidence from a population-based longitudinal study in England. | Ajnakina O et al. | — | 2023 | → |
| Comparative Assessment of Outcomes in Drug Treatment for Smoking Cessation and Role of Genetic Polymorphisms of Human Nicotinic Acetylcholine Receptor Subunits. | Muderrisoglu A et al. | — | 2022 | → |
| Effects of Genetic Variants in the Nicotine Metabolism Pathway on Smoking Cessation. | Li H et al. | — | 2022 | → |
| The Promise of Polygenic Risk Prediction in Smoking Cessation: Evidence From Two Treatment Trials. | Bray M et al. | — | 2022 | → |
| The shared genetic architecture of smoking behaviours and psychiatric disorders: Evidence from a population-based longitudinal study in England | Ajnakina O et al. | — | 2022 | — |
| Associations Between Smoking Abstinence, Inhibitory Control, and Smoking Behavior: An fMRI Study. | Bell S et al. | — | 2021 | → |
| Genes identified in rodent studies of alcohol intake are enriched for heritability of human substance use. | Huggett SB et al. | — | 2021 | → |
| Pharmacogenetics factors influencing smoking cessation success; the importance of nicotine metabolism. | Perez-Paramo YX et al. | — | 2021 | → |
| The Role of Pharmacogenetics in Smoking. | El-Boraie A et al. | — | 2021 | → |
| Comprehensive Parent-Metabolite PBPK/PD Modeling Insights into Nicotine Replacement Therapy Strategies. | Kovar L et al. | — | 2020 | → |
| Molecular Mechanisms Associated with Nicotine Pharmacology and Dependence. | Fowler CD et al. | — | 2020 | → |
| Pharmacogenomics of Nicotine Metabolism: Novel CYP2A6 and CYP2B6 Genetic Variation Patterns in Alaska Native and American Indian Populations. | Claw KG et al. | — | 2020 | → |
| The Role of A Priori-Identified Addiction and Smoking Gene Sets in Smoking Behaviors. | Evans LM et al. | — | 2020 | → |
| Neurogenetic determinants and mechanisms of addiction to nicotine and smoked tobacco. | Sharp BM et al. | — | 2019 | → |
| Acute Effects of Aerobic Exercise on Affect and Smoking Craving in the Weeks Before and After a Cessation Attempt. | Abrantes AM et al. | — | 2018 | → |
| From genes to treatments: a systematic review of the pharmacogenetics in smoking cessation. | Salloum NC et al. | — | 2018 | → |
| Genetic variation in CHRNA7 and CHRFAM7A is associated with nicotine dependence and response to varenicline treatment. | Cameli C et al. | — | 2018 | → |
| The dopamine transporter role in psychiatric phenotypes. | Salatino-Oliveira A et al. | — | 2018 | → |
| A Drosophila model for developmental nicotine exposure. | Velazquez-Ulloa NA | — | 2017 | → |
| A protocadherin gene cluster regulatory variant is associated with nicotine withdrawal and the urge to smoke. | Jensen KP et al. | — | 2017 | → |
| Association of the DBH Polymorphism rs3025343 With Smoking Cessation in a Large Population-Based Sample. | Hirvonen K et al. | — | 2017 | → |
| Pathways to smoking behaviours: biological insights from the Tobacco and Genetics Consortium meta-analysis. | Minicã CC et al. | — | 2017 | → |
| SNPs within CHRNA5-A3-B4 and CYP2A6/B6 are associated with smoking dependence but not with tobacco dependence treatment outcomes in the Czech population. | Hubacek JA et al. | — | 2017 | → |
| Associations of cytochrome P450 oxidoreductase genetic polymorphisms with smoking cessation in a Chinese population. | Li H et al. | — | 2016 | → |
| Correlates of nicotine withdrawal severity in smokers during a smoke-free psychiatric hospitalization. | Soyster P et al. | — | 2016 | → |
| Meta-analysis reveals significant association of 3'-UTR VNTR in SLC6A3 with smoking cessation in Caucasian populations. | Ma Y et al. | — | 2016 | → |
| Smokescreen: a targeted genotyping array for addiction research. | Baurley JW et al. | — | 2016 | → |
| Association of 5-HTTLPR polymorphism with smoking behaviors: A meta-analysis. | Li H et al. | — | 2015 | → |
| Biomarkers of Response to Smoking Cessation Pharmacotherapies: Progress to Date. | Mamoun M et al. | — | 2015 | → |
| CHRNA4 rs1044396 is associated with smoking cessation in varenicline therapy. | Rocha Santos J et al. | — | 2015 | → |
| CYP2B6 rs2279343 polymorphism is associated with smoking cessation success in bupropion therapy. | Tomaz PR et al. | — | 2015 | → |
| Lack of Associations of CHRNA5-A3-B4 Genetic Variants with Smoking Cessation Treatment Outcomes in Caucasian Smokers despite Associations with Baseline Smoking. | Tyndale RF et al. | — | 2015 | → |
| Nicotine withdrawal. | McLaughlin I et al. | — | 2015 | → |
| Nicotine withdrawal in selectively bred high and low nicotine preferring rat lines. | Nesil T et al. | — | 2015 | → |
| Pharmacogenetics of nicotine and associated smoking behaviors. | Tanner JA et al. | — | 2015 | → |
| The significant association of Taq1A genotypes in DRD2/ANKK1 with smoking cessation in a large-scale meta-analysis of Caucasian populations. | Ma Y et al. | — | 2015 | → |
| Association of CHRNA5-A3-B4 SNP rs2036527 with smoking cessation therapy response in African-American smokers. | Zhu AZ et al. | — | 2014 | → |
| CHRNA5 variant predicts smoking cessation in patients with acute myocardial infarction. | Chen LS et al. | — | 2014 | → |
| Cognitive function during nicotine withdrawal: Implications for nicotine dependence treatment. | Ashare RL et al. | — | 2014 | → |
| Parkinson disease and smoking revisited: ease of quitting is an early sign of the disease. | Ritz B et al. | — | 2014 | → |
| Pharmacogenetics of smoking: how far to the clinic? | Quaak M et al. | — | 2014 | → |
| Polygenic risk and the developmental progression to heavy, persistent smoking and nicotine dependence: evidence from a 4-decade longitudinal study. | Belsky DW et al. | — | 2013 | → |
| A systematic review of the A118G (Asn40Asp) variant of OPRM1 in relation to smoking initiation, nicotine dependence and smoking cessation. | Verhagen M et al. | — | 2012 | → |
| CD-1 mice Show Individual Differences in Nicotine Preference in a Modified Two-Bottle Oral Self-Administration Model. | Cao J et al. | — | 2012 | → |
| Persistent heavy smoking as risk factor for major depression (MD) incidence--evidence from a longitudinal Canadian cohort of the National Population Health Survey. | Khaled SM et al. | — | 2012 | → |
| Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes. | Gold AB et al. | — | 2012 | → |
| Smoking cessation pharmacogenetics: analysis of varenicline and bupropion in placebo-controlled clinical trials. | King DP et al. | — | 2012 | → |
| Strain-dependent effects of acute, chronic, and withdrawal from chronic nicotine on fear conditioning. | Portugal GS et al. | — | 2012 | → |
| Are smokers interested in genetic testing for smoking addiction? A socio-cognitive approach. | Smerecnik C et al. | — | 2011 | → |
| Biomarkers to optimize the treatment of nicotine dependence. | Schnoll RA et al. | — | 2011 | → |
| Markers in the 15q24 nicotinic receptor subunit gene cluster (CHRNA5-A3-B4) predict severity of nicotine addiction and response to smoking cessation therapy. | Sarginson JE et al. | — | 2011 | → |
| Pharmacogenetics of alcohol, nicotine and drug addiction treatments. | Sturgess JE et al. | — | 2011 | → |
| Population composition, public policy, and the genetics of smoking. | Boardman JD et al. | — | 2011 | → |
| The galanin receptor 1 gene associates with tobacco craving in smokers seeking cessation treatment. | Lori A et al. | — | 2011 | → |
| The German multi-centre study on smoking-related behavior-description of a population-based case-control study. | Lindenberg A et al. | — | 2011 | → |
| Associations of variants in CHRNA5/A3/B4 gene cluster with smoking behaviors in a Korean population. | Li MD et al. | — | 2010 | → |
| Cognitive effects of nicotine: genetic moderators. | Herman AI et al. | — | 2010 | → |
| Common and unique biological pathways associated with smoking initiation/progression, nicotine dependence, and smoking cessation. | Wang J et al. | — | 2010 | → |
| Convergent evidence that choline acetyltransferase gene variation is associated with prospective smoking cessation and nicotine dependence. | Ray R et al. | — | 2010 | → |
| Nicotine withdrawal symptoms in adolescent and adult twins. | Pergadia ML et al. | — | 2010 | → |
| Pharmacogenetics of smoking cessation therapy. | Kortmann GL et al. | — | 2010 | → |
| Association of tobacco dependence and quit attempt duration with Rasch-modeled withdrawal sensitivity using retrospective measures. | Javitz HS et al. | — | 2009 | → |
| A testable prognostic model of nicotine dependence. | Ramoni RB et al. | — | 2009 | → |
| Constitutional mechanisms of vulnerability and resilience to nicotine dependence. | Hiroi N et al. | — | 2009 | → |
| Genetic variation as a predictor of smoking cessation success. A promising preventive and intervention tool for chronic respiratory diseases? | Quaak M et al. | — | 2009 | → |
| Implications of gene-drug interactions in smoking cessation for improving the prevention of chronic degenerative diseases. | Quaak M et al. | — | 2009 | → |
| New findings on nicotine addiction and treatment. | Rose JE | — | 2009 | → |
| Nicotine abstinence genotyping: assessing the impact on smoking cessation clinical trials. | Uhl GR et al. | — | 2009 | → |
| Nicotine dependence: biology, behavior, and treatment. | Ray R et al. | — | 2009 | → |
| Sex heterogeneity in pharmacogenetic smoking cessation clinical trials. | Schnoll RA et al. | — | 2009 | → |
| The effect of catechol-O-methyltransferase Met/Val functional polymorphism on smoking cessation: retrospective and prospective analyses in a cohort study. | Omidvar M et al. | — | 2009 | → |
| ADHD and smoking: from genes to brain to behavior. | McClernon FJ et al. | — | 2008 | → |
| Educational attainment, smoking initiation and lifetime nicotine dependence among male Vietnam-era twins. | McCaffery JM et al. | — | 2008 | → |
| Genes and cigarette smoking. | Munafò MR et al. | — | 2008 | → |
| Genetics of nicotine dependence and pharmacotherapy. | Lessov-Schlaggar CN et al. | — | 2008 | → |
| Genetic variability in nicotinic acetylcholine receptors and nicotine addiction: converging evidence from human and animal research. | Portugal GS et al. | — | 2008 | → |
| Lack of association between serotonin transporter gene polymorphism 5-HTTLPR and smoking among Polish population: a case-control study. | Sieminska A et al. | — | 2008 | → |
| Molecular genetics of successful smoking cessation: convergent genome-wide association study results. | Uhl GR et al. | — | 2008 | → |
| Neuroimaging, genetics and the treatment of nicotine addiction. | Ray R et al. | — | 2008 | → |
| Primary care physicians' willingness to offer a new genetic test to tailor smoking treatment, according to test characteristics. | Shields AE et al. | — | 2008 | → |
| Concordance rates for smoking among African-American twins. | Whitfield KE et al. | — | 2007 | → |
| Examining the heritability of a laboratory-based smoking endophenotype: initial results from an experimental twin study. | Ray LA et al. | — | 2007 | → |
| Genetics and smoking behavior. | Schnoll RA et al. | — | 2007 | → |
| Genetics and smoking cessation improving outcomes in smokers at risk. | Lerman CE et al. | — | 2007 | → |
| Molecular genetics of nicotine dependence and abstinence: whole genome association using 520,000 SNPs. | Uhl GR et al. | — | 2007 | → |
| Overview of the pharmacogenomics of cigarette smoking. | Ho MK et al. | — | 2007 | → |
| Pharmacogenetics and smoking cessation with nicotine replacement therapy. | Ray R et al. | — | 2007 | → |
| A genome-wide screen for nicotine dependence susceptibility loci. | Swan GE et al. | — | 2006 | → |
| Symptoms in smokers trying to quit. | Tomson T et al. | — | 2006 | → |
| Association of catechol-O-methyltransferase with smoking cessation in two independent studies of women. | Colilla S et al. | — | 2005 | → |
| [Genetic basis of tobacco dependence]. | Barrueco M et al. | — | 2005 | → |
| Genetic influences on smoking: a brief review. | Al Koudsi N et al. | — | 2005 | → |
| Subjective reactions to cocaine and marijuana are associated with abuse and dependence. | Grant JD et al. | — | 2005 | → |
| A general causal model to guide alcohol, tobacco, and illicit drug prevention: assessing the research evidence. | Birckmayer JD et al. | — | 2004 | → |
| Genetics of tobacco use. | Maserejian NN et al. | — | 2004 | → |
| Tobacco cessation: new challenges, new opportunities. | Hopper JA et al. | — | 2003 | → |